Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Cancer Treatment market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

102 Item(s)

Page 1 of 11

  1. Global Lung Cancer Therapeutics Market 2016-2020

    By: Technavio
    , Published: Nov-2016
    , Product code: IRTNTR10849
    The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
    $2,500.00

  2. Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Sep-2016
    , Product code: HBI-1321015
    The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed as well as developing countries; favorable government research funding for cancer research; and rising R&D expenditures by pharmaceutical companies. However, poorly suited regulatory and reimbursement systems of biomarker tests and huge capital investments for biomarker discovery and development are restricting the growth of this market.
    $3,900.00

  3. Global Cancer Diagnostics Device Market 2016-2020

    By: Technavio
    , Published: Jun-2016
    , Product code: IRTNTR9265
    The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.
    $2,500.00

  4. Global Cancer Immunotherapies Market 2016-2020

    By: Technavio
    , Published: Apr-2016
    , Product code: IRTNTR8400
    The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
    $2,500.00

  5. Global Cancer Diagnostics Partnering 2010-2016 - Apr2016.pdf

    By: Current Partnering
    , Published: Apr-2016
    , Product code: CP22013
    The Global Cancer Diagnostics Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

  6. Array Biopharma Partnering Deals and Alliances 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP1162
    This report provides all the information you require to better understand Array Biopharma and its partnering interests and activities since 2010
    $1,495.00

  7. Bavarian Nordic Partnering Deals and Alliances 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP1149
    This report provides all the information you require to better understand Bavarian Nordic and its partnering interests and activities since 2010
    $1,495.00

  8. Dendreon Partnering Deals and Alliances 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP1163
    This report provides all the information you require to better understand Dendreon and its partnering interests and activities since 2010.
    $1,495.00

  9. Global Bladder Cancer Partnering 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2201bla
    Provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies
    $1,495.00

  10. Global Brain Cancer Partnering 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2201bra
    Provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies .
    $1,495.00

102 Item(s)

Page 1 of 11